anewmeds.com - Nilai perusahaan marang pendapatan WENA

Anew Medical, Inc. (WENA) relies on external laboratories for research, which will enable premium pricing through patents in the future. The EV/Revenue multiple helps correlate the total business value with revenues excluding debt, while determines the latest valuation metric. Demand for neurological treatment remains stable and is independent of economic cycles.
anewmeds.com - rincian analitis lan metrik utama (WENA)

The market evaluates the prospects of Anew Medical, Inc. (WENA) through the lens of future breakthroughs, as this metric compares the total enterprise value of the business with its annual revenue, excluding the impact of debt. By analyzing the EV/Sales ratio, an investor can see an overvaluation given the lack of current revenue from neurodegenerative disease therapies, which is characteristic of high-risk R&D stage assets.